Glatopa and Joint pain - a phase IV clinical study of FDA data

Summary:

Joint pain is reported as a side effect among people who take Glatopa (glatiramer acetate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Oxycodone, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Joint pain when taking Glatopa. It is created by eHealthMe based on reports of 6,512 people who have side effects when taking Glatopa from the FDA, and is updated regularly.

What is Glatopa?

Glatopa has active ingredients of glatiramer acetate. eHealthMe is studying from 6,518 Glatopa users. Check the latest studies of Glatopa.

What is Joint pain?

Joint pain is found to be associated with 3,331 drugs and 5,207 conditions by eHealthMe. Check the latest studies of Joint pain.

On Jul, 14, 2026

6,512 people reported to have side effects when taking Glatopa.
Among them, 62 people (0.95%) have Joint pain.

Among these 62 people:

How long have people been on Glatopa when they have Joint pain? *

What is the gender of people who have Joint pain when taking Glatopa? *

female: 70 %
male: 30 %

What is the age of people who have Joint pain when taking Glatopa? *

What are other drugs people take besides Glatopa? *

What are other side effects people have besides Joint pain? *

Back Pain: 14 people, 22.58%
Weakness: 13 people, 20.97%
Pain In Extremity: 11 people, 17.74%
Fatigue (feeling of tiredness): 11 people, 17.74%
Injection Site Pain: 10 people, 16.13%
Injection Site Mass: 9 people, 14.52%
Headache (pain in head): 9 people, 14.52%
Pain: 9 people, 14.52%
Nausea (feeling of having an urge to vomit): 8 people, 12.90%
Muscle Aches (muscle pain): 7 people, 11.29%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 43 people, 69.35%
Pain: 5 people, 8.06%
High Blood Cholesterol: 5 people, 8.06%
Diabetes: 4 people, 6.45%
Insomnia (sleeplessness): 3 people, 4.84%
Neuralgia (pain in one or more nerves): 3 people, 4.84%
Muscle Spasms (muscle contraction): 3 people, 4.84%
High Blood Pressure: 3 people, 4.84%
Sinus Disorder (disease of sinus): 2 people, 3.23%
Dry Skin: 2 people, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Glatopa and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glatopa:

Glatopa (6,518 reports)

Joint pain treatments and more:

Joint pain (542,934 reports)

Browse all side effects of Glatopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint pain:

Joint pain (3,331 drugs)

Browse all the conditions that are associated with Joint pain:

Joint pain (5,207 conditions)

Related publications that referenced our studies

Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .
Michaud CJ, Bockheim HM, Nabeel M, Daum TE, "Diagnosis of Exclusion: A Case Report of Probable Glatiramer Acetate-Induced Eosinophilic Myocarditis", Case reports in neurological medicine, 2014 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on glatiramer acetate (the active ingredients of Glatopa) and Glatopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.